Vident Advisory, LLC Vir Biotechnology, Inc. Transaction History
Vident Advisory, LLC
- $3.62 Trillion
- Q2 2024
A detailed history of Vident Advisory, LLC transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 17,419 shares of VIR stock, worth $127,855. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,419
Previous 12,028
44.82%
Holding current value
$127,855
Previous $122 Million
27.24%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VIR
# of Institutions
233Shares Held
87.6MCall Options Held
231KPut Options Held
132K-
Sb Investment Advisers (Uk) LTD London, X016.7MShares$122 Million1.37% of portfolio
-
Black Rock Inc. New York, NY16.4MShares$121 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.8MShares$94.3 Million0.0% of portfolio
-
State Street Corp Boston, MA5.09MShares$37.4 Million0.0% of portfolio
-
Baillie Gifford & CO3.92MShares$28.8 Million0.03% of portfolio
About Vir Biotechnology, Inc.
- Ticker VIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 132,638,000
- Market Cap $974M
- Description
- Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...